Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
IEEE Rev Biomed Eng ; PP2022 Oct 21.
Article in English | MEDLINE | ID: covidwho-2231267

ABSTRACT

At the beginning of the COVID-19 pandemic, there was significant hype about the potential impact of artificial intelligence (AI) tools in combatting COVID-19 on diagnosis, prognosis, or surveillance. However, AI tools have not yet been widely successful. One of the key reason is the COVID-19 pandemic has demanded faster real-time development of AI-driven clinical and health support tools, including rapid data collection, algorithm development, validation, and deployment. However, there was not enough time for proper data quality control. Learning from the hard lessons in COVID-19, we summarize the important health data quality challenges during COVID-19 pandemic such as lack of data standardization, missing data, tabulation errors, and noise and artifact. Then we conduct a systematic investigation of computational methods that address these issues, including emerging novel advanced AI data quality control methods that achieve better data quality outcomes and, in some cases, simplify or automate the data cleaning process. We hope this article can assist healthcare community to improve health data quality going forward with novel AI development.

2.
Crit Care Med ; 50(2): 212-223, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1735675

ABSTRACT

OBJECTIVES: Body temperature trajectories of infected patients are associated with specific immune profiles and survival. We determined the association between temperature trajectories and distinct manifestations of coronavirus disease 2019. DESIGN: Retrospective observational study. SETTING: Four hospitals within an academic healthcare system from March 2020 to February 2021. PATIENTS: All adult patients hospitalized with coronavirus disease 2019. INTERVENTIONS: Using a validated group-based trajectory model, we classified patients into four previously defined temperature trajectory subphenotypes using oral temperature measurements from the first 72 hours of hospitalization. Clinical characteristics, biomarkers, and outcomes were compared between subphenotypes. MEASUREMENTS AND MAIN RESULTS: The 5,903 hospitalized coronavirus disease 2019 patients were classified into four subphenotypes: hyperthermic slow resolvers (n = 1,452, 25%), hyperthermic fast resolvers (1,469, 25%), normothermics (2,126, 36%), and hypothermics (856, 15%). Hypothermics had abnormal coagulation markers, with the highest d-dimer and fibrin monomers (p < 0.001) and the highest prevalence of cerebrovascular accidents (10%, p = 0.001). The prevalence of venous thromboembolism was significantly different between subphenotypes (p = 0.005), with the highest rate in hypothermics (8.5%) and lowest in hyperthermic slow resolvers (5.1%). Hyperthermic slow resolvers had abnormal inflammatory markers, with the highest C-reactive protein, ferritin, and interleukin-6 (p < 0.001). Hyperthermic slow resolvers had increased odds of mechanical ventilation, vasopressors, and 30-day inpatient mortality (odds ratio, 1.58; 95% CI, 1.13-2.19) compared with hyperthermic fast resolvers. Over the course of the pandemic, we observed a drastic decrease in the prevalence of hyperthermic slow resolvers, from representing 53% of admissions in March 2020 to less than 15% by 2021. We found that dexamethasone use was associated with significant reduction in probability of hyperthermic slow resolvers membership (27% reduction; 95% CI, 23-31%; p < 0.001). CONCLUSIONS: Hypothermics had abnormal coagulation markers, suggesting a hypercoagulable subphenotype. Hyperthermic slow resolvers had elevated inflammatory markers and the highest odds of mortality, suggesting a hyperinflammatory subphenotype. Future work should investigate whether temperature subphenotypes benefit from targeted antithrombotic and anti-inflammatory strategies.


Subject(s)
Body Temperature , COVID-19/pathology , Hyperthermia/pathology , Hypothermia/pathology , Phenotype , Academic Medical Centers , Aged , Anti-Inflammatory Agents/therapeutic use , Biomarkers/blood , Blood Coagulation , Cohort Studies , Dexamethasone/therapeutic use , Female , Humans , Inflammation , Male , Middle Aged , Organ Dysfunction Scores , Retrospective Studies , SARS-CoV-2
3.
IEEE J Biomed Health Inform ; 25(7): 2376-2387, 2021 07.
Article in English | MEDLINE | ID: covidwho-1328979

ABSTRACT

Researchers seek help from deep learning methods to alleviate the enormous burden of reading radiological images by clinicians during the COVID-19 pandemic. However, clinicians are often reluctant to trust deep models due to their black-box characteristics. To automatically differentiate COVID-19 and community-acquired pneumonia from healthy lungs in radiographic imaging, we propose an explainable attention-transfer classification model based on the knowledge distillation network structure. The attention transfer direction always goes from the teacher network to the student network. Firstly, the teacher network extracts global features and concentrates on the infection regions to generate attention maps. It uses a deformable attention module to strengthen the response of infection regions and to suppress noise in irrelevant regions with an expanded reception field. Secondly, an image fusion module combines attention knowledge transferred from teacher network to student network with the essential information in original input. While the teacher network focuses on global features, the student branch focuses on irregularly shaped lesion regions to learn discriminative features. Lastly, we conduct extensive experiments on public chest X-ray and CT datasets to demonstrate the explainability of the proposed architecture in diagnosing COVID-19.


Subject(s)
COVID-19/diagnostic imaging , Deep Learning , Radiographic Image Interpretation, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Algorithms , Humans , Lung/diagnostic imaging , SARS-CoV-2
4.
Pediatr Emerg Care ; 37(2): 123-125, 2021 Feb 01.
Article in English | MEDLINE | ID: covidwho-1054397

ABSTRACT

OBJECTIVES: To determine if boys with acute testicular torsion, a surgical emergency requiring prompt diagnosis and treatment to optimize salvage of the testicle, delayed presentation to a medical facility and experienced an extended duration of symptoms (DoS), and secondarily, a higher rate of orchiectomy, during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Single-center, descriptive retrospective chart review of boys presenting with acute testicular torsion from March 15, to May 4, 2020 ("during COVID-19" or group 2), as well as for the same time window in the 5-year period from 2015 to 2019 ("pre-COVID-19" or group 1). RESULTS: A total of 78 boys met inclusion criteria, group 1 (n = 57) and group 2 (n = 21). The mean age was 12.86 ± 2.63 (group 1) and 12.86 ± 2.13 (group 2). Mean DoS before presentation at a medical facility was 23.2 ± 35.0 hours in group 1 compared with 21.3 ± 29.7 hours in group 2 (P < 0.37). When DoS was broken down into acute (<24 hours) versus delayed (≥24 hours), 41 (71.9%) of 57 boys in group 1 and 16 (76.2%) of 21 boys in group 2 presented within less than 24 hours of symptom onset (P < 0.78). There was no difference in rate of orchiectomy between group 1 and group 2 (44.7% vs 25%, P < 0.17), respectively. CONCLUSIONS: Boys with acute testicular torsion in our catchment area did not delay presentation to a medical facility from March 15, to May 4, 2020, and did not subsequently undergo a higher rate of orchiectomy.


Subject(s)
COVID-19/epidemiology , Spermatic Cord Torsion/surgery , Adolescent , Child , Emergency Service, Hospital , Humans , Male , Orchiectomy/statistics & numerical data , Retrospective Studies , SARS-CoV-2 , Spermatic Cord Torsion/diagnosis , Spermatic Cord Torsion/epidemiology , Testis/surgery , Time Factors , Time-to-Treatment
SELECTION OF CITATIONS
SEARCH DETAIL